PMON91 Late Presentation of Pituitary Apoplexy Following Gonadotropin-Releasing Hormone Agonist for Prostate Cancer Treatment

BACKGROUND: Pituitary apoplexy (PA) is characterized by sudden increase in pituitary gland volume secondary to ischemia and/or necrosis. Certain predisposing factors can result in PA and use of gonadotropin-releasing hormone (GnRH) agonist for prostate cancer (PCa) is one such condition. We present...

Descripción completa

Detalles Bibliográficos
Autores principales: Raj, Rishi, Elshimy, Ghada, Owen, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625137/
http://dx.doi.org/10.1210/jendso/bvac150.1183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625137/
http://dx.doi.org/10.1210/jendso/bvac150.1183

Ejemplares similares